About the Event
2022-2023 Funding Calls
On Tuesday, October 11, 2022 the CARB-X website will have a pre-recorded video and details on how to apply for CARB-X’s 2022-2023 funding calls. The application portal will open on October 17 at 9am ET to submit materials.
Register for one of the free public webinars to discuss the scope of the funding rounds, application process, and answer questions. Same content at two different times:
- October 20, 2022 | 8AM ET | Click to register here! Eastern Time (US and Canada).
The CARB-X funding rounds have three distinct product themes:
- Oral therapeutics: the scope is restricted to oral products with several syndromes and causative agents possible, including respiratory tract infections, urinary tract infections and syndromes caused primarily by Gram-positive pathogens. In all cases, activity against multidrug-resistant organisms on the WHO and CDC bacterial threat lists is essential.
- Vaccines for neonatal sepsis: the scope is restricted to vaccines focused on the prevention of neonatal sepsis, targeting several possible bacterial species, including Klebsiella pneumoniae, Escherichia coli (ETEC or urinary), Acinetobacter baumannii and Staphylococcus aureus. While a maternal vaccine is sought, it is expected that a commercial indication could be proposed.
- Gonorrhea products: the scope is open to products that address Neisseria gonorrhoeae, including, for example, oral therapeutics, low-cost vaccines and rapid, point-of-care diagnostics. Products must address both drug-sensitive and drug-resistant scenarios.
Expressions of interest (EOI) for all three themes may be submitted during the following submission windows:
- October 17 at 09:00 ET to October 31, 2022 at 23:59 ET
- January 16 at 09:00 ET to January 30, 2023 at 23:59 ET
- April 17 at 09:00 ET to May 1, 2023 at 23:59 ET
Brought to you by CARB-X.